Skip to search formSkip to main contentSkip to account menu

Acute GVH disease

Known as: Acute graft-versus-host disease, Graft versus host disease, acute, GVHD, acute 
A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI… 
National Institutes of Health

Related topics

Related topics

2 relations
Immune System DiseasesImmunologic Deficiency Syndromes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
A biomarker panel for acute graft-versus-host disease.
No validated biomarkers exist for acute graft-versus-host disease (GVHD). We screened plasma with antibody microarrays for 120… 
Review
2003
Review
2003
Tacrolimus: a further update of its use in the management of organ transplantation.
UNLABELLED Extensive clinical use has confirmed that tacrolimus (Prograf) is a key option for immunosuppression after… 
Highly Cited
2000
Highly Cited
2000
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
Peripheral blood stem cells (PBSC) obtained from granulocyte-colony stimulating factor (G-CSF)-mobilized donors are increasingly… 
Highly Cited
2000
Highly Cited
2000
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group…
Peripheral blood cells are increasingly used in place of bone marrow as a source of hematopoietic stem cells for allogeneic… 
Highly Cited
2000
Highly Cited
2000
Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.
We evaluated the efficacy, toxicity, and outcome of preemptive ganciclovir (GCV) therapy in 80 cytomegalovirus (CMV)-seropositive… 
Highly Cited
1999
Highly Cited
1999
Transplantation of anergic histoincompatible bone marrow allografts.
BACKGROUND Successful allogeneic bone marrow transplantation relies on global immunosuppression or elimination of T cells. In… 
Highly Cited
1998
Highly Cited
1998
Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient.
In unrelated marrow transplantation, the benefit of matching class II HLA-DRB1 and DQB1 alleles of the donor and recipient is… 
Review
1990
Review
1990
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.
We have reviewed results of secondary therapy in 427 patients with acute graft-versus-host disease (GVHD) who did not have a… 
Highly Cited
1990
Highly Cited
1990
Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.
We have analyzed the long term outcome of 197 patients who were treated for grade II to IV acute graft-versus-host disease (GVHD… 
Review
1989
Review
1989
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
To determine the incidence of secondary cancers after bone marrow transplantation, we reviewed the records of all patients at our… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)